Treatment of psoriatic arthritis with biological agents
Revmatologický ústav, Praha
Čes. Revmatol., , 2004, No. 4, p. 175-183.
Psoriatic arthritis is a potentially serious disorder leading to a significant disability in 20–30 % ofpatients. Pharmacological treatment is limited to non-steroidal anti-inflammatory drugs, sulfasalazine,methotrexate and cyclosporine A. In contrast to rheumatoid arthritis, there has not been anybiological agent registered in the Czech Republic yet. The registration is expected in 2005. Indicationcriteria and methods of monitoring of biological treatment before its assumed registration in2005 are summarized in the present paper.
psoriatic arthritis, biologic treatment, standard methods
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP
Dermatology & STDs